Journal
CELL DEATH AND DIFFERENTIATION
Volume 11, Issue 3, Pages 321-330Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.cdd.4401375
Keywords
endoplasmic reticulum; SERCA pump; calreticulin; store-operated Ca2+ current; Bcl-2
Categories
Ask authors/readers for more resources
Neuroendocrine (NE) differentiation is a hallmark of advanced, androgen-independent prostate cancer, for which there is no successful therapy. NE tumor cells are nonproliferating and escape apoptotic cell death; therefore, an understanding of the apoptotic status of the NE phenotype is imperative for the development of new therapies for prostate cancer. Here, we report for the first time on alterations in intracellular Ca2+ homeostasis, which is a key factor in apoptosis, caused by NE differentiation of androgen-dependent prostate cancer epithelial cells. NE-differentiating regimens, either cAMP elevation or androgen deprivation, resulted in a reduced endoplasmic reticulum Ca2+-store content due to both SERCA 2b Ca2+ ATPase and luminal Ca2+ binding/storage chaperone calreticulin underexpression, and to a downregulated store-operated Ca2+ current. NE-differentiated cells showed enhanced resistance to thapsigargin- and TNF-alpha-induced apoptosis, unrelated to antiapoptotic Bcl-2 protein overexpression. Our results suggest that targeting the key players determining Ca2+ homeostasis in an attempt to enhance the proapoptotic potential of malignant cells may prove to be a useful strategy in the treatment of advanced prostate cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available